Teal Health secures $10M for at-home cervical cancer screening
The company will use the funds to accelerate development of its screening device.
Related Articles
Imagine360 acquires Ardent Health 3rd-party administrator HealthFirst
Self-funded Pennsylvania-based health plan Imagine360 is buying Ardent Health’s third-party administrator (TPA) HealthFirst, the two companies revealed Jan. 15. | Alternative health plan Imagine360 is…
Americans see AI as key to cutting healthcare costs
“Discover the public’s perception of AI in healthcare and its potential to improve outcomes and reduce costs, according to a recent survey by The Harris…
New materials with interlocking parts can flow like liquid or contract like muscles
Made like miniature chainmail armor, these polymers have strange—and useful—properties
OpenAI has created an AI model for longevity science
OpenAI is making a foray into scientific discovery with an AI built to help manufacture stem cells.
Ascend Medical, Amenities Health unveil mobile app for digital
The app will allow patients to register digitally in less than 60 seconds and schedule appointments.
Microbial Cell Factories Help Scientists Produce Understudied Plant Hormones in Bulk
By co-culturing E. coli and Baker’s yeast, scientists have a way to manufacture large quantities of plant molecules for research use.
JPM25 Day 3: Why 2025 will be a hot year for M&A; Talkspace rolls out new AI-powered tool for therapists
SAN FRANCISCO—The third day of the annual J.P. | The third day of the annual J.P. Morgan Healthcare Conference brought presentations from GoodRx, Health Catalyst,…
Intuitive CEO drills down on da Vinci 5 rollout, force feedback debate
Gary Guthart gave a glimpse of surgeons’ initial response to the new robot at the J.P. Morgan Healthcare Conference.
News at a glance: Longest continuous ice core, formaldehyde’s risks, and building Africa’s science workforce
The latest in science and policy
Repetitive HIV Immunization Can Elicit Anti-Immune Complex Antibodies
Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus.